DENVER, Sept. 23, 2016 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically driven, performance-lifestyle sports nutrition company, hosted the First Annual Submit Cancer Jiu-Jitsu Charity Event in August.  With over 450 attendees and raising over $60,000 for the Children's Hospital Foundation Colorado, 100% of the proceeds went back to charity with MusclePharm funding the event.

Former UFC Light Heavyweight Champion, Lyoto Machida, walks out on the catwalk before his fight at the First Annual Submit Cancer Charity Event.

"We are focusing on the things that define who we are as a brand: label and company transparency, science, customer service, and giving back,"  Says MusclePharm CEO, Ryan Drexler, "We have been extremely focused on the health of the business, and as that continues to improve and strengthen, we determined it was time for us to invest back into the community."

The event featured World-renowned Jiu-Jitsu and UFC Athletes competing against one another, as well as top local youth and adult competitions.  MusclePharm CEO and Jiu-Jitsu Brown Belt, Ryan Drexler kicked off the main card of the incredible production against UFC fighter Neil Magny.  With the help of many great sponsors such as Fight to Win Pro , the production was top rated, with stage, lights, smoke, music, catwalk and UFC Announcer, Bruce Buffer.  

The check presentation for the $60,000+ donation to Children's Hospital Foundation is scheduled for October 5, 2016, 1:00pm MST.

The event was distributed by FloGrappling:

Fight Card and results

Black Belt Results
Marcus Almeida Buchecha defeats Eliot Marshall - reverse triangle
Jake Shields defeats Lyoto Machida - heel hook SOTN FOTN
Peter Straub vs Scott Einstein Epstein - draw
Michael Alexander defeats Gilbert Jamal Smith - draw

Brown Belts
Ryan Drexler vs Neil Magny - draw
Isiah Wright defeats Tyler Larsen - heel hook SOTN FOTN

Purple Belts
Lacey Schuckman defeats Jennifer Perez - decision FOTN

Nick Gamez-Ramos defeats Kobe Amador - triangle
Eric Sainz defeats Dane MillerHass - triangle SOTN
Jaidyn "The Iron Maiden" Mueller defeats Jaya Haggerty - decision
Cameron Mellott defeats Emil Tapper - decision FOTN
Juan Martinez Jr. defeats Taishon Wilson - triangle

Savanah Cosme defeats Luci Blum - submission SOTN
Damon Jakubsen defeats Diego Garcia
Demarco Cosme defeats Emerson Preuss

About MusclePharm Corporation

MusclePharm® is a scientifically-driven, performance lifestyle company that develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. Its portfolio of recognized brands includes MusclePharm® Sport Series, Black Label and Core Series, and FitMiss™, which are available in more than 120 countries and over 50,000 retail outlets worldwide. The clinically-proven supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors, and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit To sign up to receive MusclePharm news via email, please visit

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the Securities and Exchange Commission, copies of which may be obtained from the SEC's website at Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.


Photo -


To view the original version on PR Newswire, visit:

SOURCE MusclePharm Corporation